Product Code: GVR-4-68040-845-7
Angiographic Catheters Market Summary
The global angiographic catheters market size was estimated at USD 1.61 billion in 2025 and is projected to reach USD 2.89 billion by 2033, growing at a CAGR of 7.71% from 2026 to 2033. The market growth is driven by the rising incidence of cardiovascular and peripheral vascular diseases, as well as the increasing reliance on image-guided diagnostic and interventional procedures.
The growing prevalence of coronary artery disease, cerebrovascular events, and peripheral artery disease is significantly increasing pressure on healthcare systems worldwide. Angiographic catheters play a key role in enabling precise vascular imaging, controlled contrast injection, and real-time procedural navigation. Healthcare providers are increasingly favoring minimally invasive diagnostic approaches and catheter-based interventions; consequently, the demand for angiographic catheters continues to rise across coronary, neurovascular, and peripheral endovascular procedures.
Within this broader landscape, the hydrophilic angiographic catheters market is gaining traction, driven by the need for enhanced catheter trackability, reduced friction, and improved navigation through tortuous vascular anatomy. Hydrophilic-coated catheters are increasingly preferred in complex diagnostic and interventional procedures, as they support smoother advancement, reduce procedural time, and lower the risk of vascular trauma.
The increasing prevalence of cardiovascular diseases (CVDs) remains a primary factor driving the growth of the angiographic catheters industry. According to Oxford Academic (January 2025), the global age-standardized prevalence of CVD is estimated at approximately 7,179 cases per 100,000 population, highlighting the persistent global burden of heart-related disorders. In the U.S., the prevalence of CVDs, including heart failure and cardiac arrhythmias, continues to rise, largely due to sedentary lifestyles, obesity, and associated metabolic comorbidities.
As clinicians seek earlier diagnosis and safer, minimally invasive interventions, hydrophilic angiographic catheters are increasingly adopted in both coronary and peripheral angiography. Their lubricious surface facilitates smoother vessel access and catheter manipulation, supporting higher procedural success rates in patients with complex vascular disease.
Moreover, as reported by the American Heart Association (AHA) in January 2025, in the U.S., cardiovascular disease remains a significant public health challenge, with one death occurring approximately every 34 seconds, amounting to nearly 2,500 deaths each day. This high mortality burden highlights the urgent need for timely diagnosis and effective management of vascular conditions such as coronary artery disease and stroke. Angiographic catheters are integral to this effort, as they enable detailed visualization of blood vessels, accurate contrast delivery, and real-time guidance during both diagnostic angiography and interventional procedures. Clinicians seek to detect arterial blockages earlier and intervene using minimally invasive, catheter-based techniques. Still, the persistent and widespread impact of cardiovascular disease continues to drive the clinical reliance on angiographic catheters.
Global Angiographic Catheters Market Report Segmentation
This report forecasts volume & revenue growth at the global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global angiographic catheters market report based on product type, application, material, end use, and region:
- Product Type Outlook (Unit Volume in '000 Units; Revenue in USD Million, 2021 - 2033)
- Diagnostic Catheters
- Conventional Diagnostic Catheters
- Microcatheters
- Interventional Catheters
- Guiding Catheters
- Balloon Assisted Catheters
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Coronary
- Endovascular
- Neurology
- Oncology
- Material Outlook (Revenue, USD Million, 2021 - 2033)
- Nylon
- Polyurethane
- PEBAX (Polyether block amide)
- Silicone
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
- Regional Outlook (Unit Volume in '000 Units; Revenue in USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology And Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Angiographic Catheters Market: Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Type Outlook
- 2.2.2. Application Outlook
- 2.2.3. Material Outlook
- 2.2.4. End use Outlook
- 2.3. Competitive Insights
Chapter 3. Angiographic Catheters Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Global Angiographic Catheters: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
- 3.4. Technology Landscape
- 3.5. Case Study Analysis
Chapter 4. Angiographic Catheters Market Segment Analysis, By Product Type (Revenue in USD Million; Unit Volume in '000 Units; 2021 - 2033)
(*) The chapter will include the following:
- Unit Sold, Market Value (USD Million), 2021-2033
- Growth Rates (% CAGR)
- Data split by:
- Global Total
- Regions (NA, Europe, APAC, Latin America, MEA)
- Individual countries (as listed in Chapter 8)
- 4.1. Definition and Scope
- 4.2. Product Type Market Share Analysis, 2025 & 2033
- 4.3. Segment Dashboard
- 4.4. Global Angiographic Catheters Market By Product Type Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033, For the Following
- 4.5.1. Diagnostic Catheters
- 4.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 4.5.1.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 4.5.1.3. Conventional Diagnostic Catheters
- 4.5.1.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 4.5.1.3.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 4.5.1.4. Microcatheters
- 4.5.1.4.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 4.5.1.4.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 4.5.2. Interventional Catheters
- 4.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 4.5.2.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 4.5.2.3. Guiding Catheters
- 4.5.2.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 4.5.2.3.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 4.5.2.4. Balloon Assisted Catheters
- 4.5.2.4.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 4.5.2.4.2. Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
Chapter 5. Angiographic Catheters Market Segment Analysis, By Application 2021 2033 (USD Million)
- 5.1. Definition and Scope
- 5.2. Application Market Share Analysis, 2025 & 2033
- 5.3. Segment Dashboard
- 5.4. Global Angiographic Catheters Market By Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033, For the Following
- 5.5.1. Coronary
- 5.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 5.5.2. Endovascular
- 5.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 5.5.3. Neurology
- 5.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 5.5.4. Oncology
- 5.5.4.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 6. Angiographic Catheters Market Segment Analysis, By Material 2021 2033 (USD Million)
- 6.1. Definition and Scope
- 6.2. Material Market Share Analysis, 2025 & 2033
- 6.3. Segment Dashboard
- 6.4. Global Angiographic Catheters Market By Material Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033, For the Following
- 6.5.1. Nylon
- 6.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 6.5.2. Polyurethane
- 6.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 6.5.3. PEBAX (Polyether block amide)
- 6.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 6.5.4. Silicone
- 6.5.4.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 7. Angiographic Catheters Market Segment Analysis, By End Use 2021 2033 (USD Million)
- 7.1. Definition and Scope
- 7.2. End Use Market Share Analysis, 2025 & 2033
- 7.3. Segment Dashboard
- 7.4. Global Angiographic Catheters Market By End Use Outlook
- 7.5. Market Size & Forecasts and Trend Analyses, 2021 To 2033, For the Following
- 7.5.1. Hospitals
- 7.5.1.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 7.5.2. Ambulatory Surgical Centers (ASCs)
- 7.5.2.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
- 7.5.3. Others
- 7.5.3.1. Market Estimates and Forecasts 2021 To 2033 (USD Million)
Chapter 8. Angiographic Catheters Market Segment Analysis, By Region, (Revenue in USD Million; Unit Volume in '000 Units; 2021 - 2033)
(*) For each country/region, the final report will provide:
- Market size & forecast (Revenue in USD Million; Unit Volume in '000 Units; Average Selling Price ([SD per Unit]))
- Growth Rates (% CAGR)
- Competitive Scenario
- Regulatory & reimbursement landscape
- 8.1. Regional Market Share Analysis, 2025 & 2033
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Angiographic Catheters Market Share by Region, 2025 & 2033
- 8.5. North America
- 8.5.1. North America Angiographic Catheters Market, 2021 - 2033 (USD Million)
- 8.5.2. U.S.
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. U.S. Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.5.2.5. U.S. Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.5.3. Canada
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Canada Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.5.3.5. Canada Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.5.4. Mexico
- 8.5.4.1. Key Country Dynamics
- 8.5.4.2. Competitive Scenario
- 8.5.4.3. Regulatory Framework
- 8.5.4.4. Mexico Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.5.4.5. Mexico Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6. Europe
- 8.6.1. Europe Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.2. UK
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. UK Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.2.5. UK Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.3. Germany
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Germany Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.3.5. Germany Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.4. Spain
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. Spain Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.4.5. Spain Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.5. France
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. France Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.5.5. France Average Selling Price Estimates & Forecast 2021 to 2033
- 8.6.6. Italy
- 8.6.6.1. Key Country Dynamics
- 8.6.6.2. Competitive Scenario
- 8.6.6.3. Regulatory Framework
- 8.6.6.4. Italy Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.6.5. Italy Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.7. Denmark
- 8.6.7.1. Key Country Dynamics
- 8.6.7.2. Competitive Scenario
- 8.6.7.3. Regulatory Framework
- 8.6.7.4. Denmark Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.7.5. Denmark Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.8. Sweden
- 8.6.8.1. Key Country Dynamics
- 8.6.8.2. Competitive Scenario
- 8.6.8.3. Regulatory Framework
- 8.6.8.4. Sweden Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.8.5. Sweden Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.6.9. Norway
- 8.6.9.1. Key Country Dynamics
- 8.6.9.2. Competitive Scenario
- 8.6.9.3. Regulatory Framework
- 8.6.9.4. Norway Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.6.9.5. Norway Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key Country Dynamics
- 8.7.1.2. Competitive Scenario
- 8.7.1.3. Regulatory Framework
- 8.7.1.4. Japan Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.7.1.5. Japan Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.7.2. China
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Competitive Scenario
- 8.7.2.3. Regulatory Framework
- 8.7.2.4. China Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.7.2.5. China Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.7.3. India
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Competitive Scenario
- 8.7.3.3. Regulatory Framework
- 8.7.3.4. India Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.7.3.5. India Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.7.4. South Korea
- 8.7.4.1. Key Country Dynamics
- 8.7.4.2. Competitive Scenario
- 8.7.4.3. Regulatory Framework
- 8.7.4.4. South Korea Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.7.4.5. South Korea Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.7.5. Thailand
- 8.7.5.1. Key Country Dynamics
- 8.7.5.2. Competitive Scenario
- 8.7.5.3. Regulatory Framework
- 8.7.5.4. Thailand Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.7.5.5. Thailand Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.7.6. Australia
- 8.7.6.1. Key Country Dynamics
- 8.7.6.2. Competitive Scenario
- 8.7.6.3. Regulatory Framework
- 8.7.6.4. Australia Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.7.6.5. Australia Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.8. Latin America
- 8.8.1. Latin America Angiographic Catheters Market, 2021 - 2033 (USD Million)
- 8.8.2. Brazil
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Competitive Scenario
- 8.8.2.3. Regulatory Framework
- 8.8.2.4. Brazil Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.8.2.5. Brazil Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.8.3. Argentina
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Competitive Scenario
- 8.8.3.3. Regulatory Framework
- 8.8.3.4. Argentina Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.8.3.5. Argentina Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.9. MEA
- 8.9.1. MEA Angiographic Catheters Market, 2021 - 2033 (USD Million)
- 8.9.2. South Africa
- 8.9.2.1. Key Country Dynamics
- 8.9.2.2. Competitive Scenario
- 8.9.2.3. Regulatory Framework
- 8.9.2.4. South Africa Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.9.2.5. South Africa Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.9.3. Saudi Arabia
- 8.9.3.1. Key Country Dynamics
- 8.9.3.2. Competitive Scenario
- 8.9.3.3. Regulatory Framework
- 8.9.3.4. Saudi Arabia Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.9.3.5. Saudi Arabia Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.9.4. UAE
- 8.9.4.1. Key Country Dynamics
- 8.9.4.2. Competitive Scenario
- 8.9.4.3. Regulatory Framework
- 8.9.4.4. UAE Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.9.4.5. UAE Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
- 8.9.5. Kuwait
- 8.9.5.1. Key Country Dynamics
- 8.9.5.2. Competitive Scenario
- 8.9.5.3. Regulatory Framework
- 8.9.5.4. Kuwait Angiographic Catheters Market, 2021 To 2033 (USD Million)
- 8.9.5.5. Kuwait Angiographic Catheters Market Estimates and Forecasts 2021 To 2033 (Unit Volume, In '000 Units)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company Categorization (Key innovators, market leaders, emerging players)
- 9.3. Company Market Share Analysis, 2025/2026 (%)
- 9.4. Company Profiles
- 9.4.1. Boston Scientific Corp.
- 9.4.1.1. Company overview
- 9.4.1.2. Financial performance
- 9.4.1.3. Product benchmarking
- 9.4.1.4. Strategic initiatives
- 9.4.2. Medtronic plc
- 9.4.2.1. Company overview
- 9.4.2.2. Financial performance
- 9.4.2.3. Product benchmarking
- 9.4.2.4. Strategic initiatives
- 9.4.3. Terumo Medical Corporation
- 9.4.3.1. Company overview
- 9.4.3.2. Financial performance
- 9.4.3.3. Product benchmarking
- 9.4.3.4. Strategic initiatives
- 9.4.4. Merit Medical System Inc.
- 9.4.4.1. Company overview
- 9.4.4.2. Financial performance
- 9.4.4.3. Product benchmarking
- 9.4.4.4. Strategic initiatives
- 9.4.5. B. Braun SE
- 9.4.5.1. Company overview
- 9.4.5.2. Financial performance
- 9.4.5.3. Product benchmarking
- 9.4.5.4. Strategic initiatives
- 9.4.6. MicroPort Scientific Corp.
- 9.4.6.1. Company overview
- 9.4.6.2. Financial performance
- 9.4.6.3. Product benchmarking
- 9.4.6.4. Strategic initiatives
- 9.4.7. Lepu Medical Technology (Beijing) Co Ltd
- 9.4.7.1. Company overview
- 9.4.7.2. Financial performance
- 9.4.7.3. Product benchmarking
- 9.4.7.4. Strategic initiatives
- 9.4.8. Angiodynamics Inc.
- 9.4.8.1. Company overview
- 9.4.8.2. Financial performance
- 9.4.8.3. Product benchmarking
- 9.4.8.4. Strategic initiatives
- 9.4.9. Cook Medical
- 9.4.9.1. Company overview
- 9.4.9.2. Financial performance
- 9.4.9.3. Product benchmarking
- 9.4.9.4. Strategic initiatives
- 9.4.10. Cordis
- 9.4.10.1. Company overview
- 9.4.10.2. Financial performance
- 9.4.10.3. Product benchmarking
- 9.4.10.4. Strategic initiatives